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Abstract 
Background: Breast cancer is the most common cause of cancer death among Hispanic/Latino patients. 
Similar to non-Hispanic Black women, Hispanic/Latino women are more likely to be diagnosed with later 
stage breast cancer and experience worse survival rates when compared to non-Hispanic White women. 
This study was focused on identifying predictors of inadequate follow-up of abnormal screening 
mammograms in this culturally diverse Hispanic/Latina population. 
Methods: We studied 189 subjects with abnormal or inconclusive mammograms identified from a 
prospective cohort of Hispanic/Latino women (n=1570), aged 40-75, living in Connecticut and followed 
their cancer screening experience over a 2-4 year period. Using multivariate logistic regression, we 
identified independent predictors of inadequate follow-up of an abnormal mammogram. 
Results: Over 31% of women requiring immediate or short-term follow-up did not receive this care within 
three months of the recommended return date. Patient body mass index, age, pain experienced during the 
mammogram, and a subject’s perceived control over health outcomes were significant independent 
predictors of inadequate follow-up. Self-rated health was initially identified as a significant predictor, but 
was explained through stratification by patient comorbidities. 
Conclusion: While inadequate follow-up of abnormal mammograms undermines the potential benefits of 
mammography screening for all women, the observed differences in this study may have implications for 
the persistent ethnic differences in breast cancer stage at diagnosis and survival. With few published studies 
that address cancer screening on Hispanic/Latinas residing in the Northeastern, US, more research is needed 
to identify factors that contribute to poor follow-up following cancer screening tests in this population of 




Breast cancer is the leading cause of female cancer mortality in Hispanic/Latinas[1]. Although the mortality 
rates for Hispanic/Latinas are favorable compared with those reported for White women, this in part reflects 
the lower incidence. In fact, among Hispanic/Latina women diagnosed with breast cancer, there is a 
disturbing trend toward earlier age at diagnosis, later stage cancer at diagnosis, more aggressive tumor 
characteristics, and poorer survival[1-3].  Furthermore, the 2013 National Health Interview Survey reports 
that 45.9% of Hispanic/Latina women indicate receiving a screening mammogram in the past year 
compared to 52.1% of White women, a difference which may partially explains these trends[4]. Since the 
real benefit of cancer screening comes with regular screening at appropriate intervals, self-reports of low 
adherence to guidelines over time is of concern. While there could be many factors contributing to lower 
screening effectiveness in Hispanic/Latino women, the aim of this paper is to determine the predictors of 
inadequate follow-up for abnormal or inconclusive mammograms. 
 
The majority of current research on this topic has been focused on specific interventions in order to address 
this disparity in screening. This has included a wide range of approaches, such as a text-message 
intervention[13], a multi-level community/home intervention[14], and a patient navigation program[15]. 
While there has been mixed success with these interventions, foundational research into the causes of this 
disparity in breast cancer screenings is lacking. To our knowledge, there are no published reports that 
prospectively investigate on inadequate follow-up for screening mammograms within the Hispanic/Latino 
population. Findings from our study may inform future interventions developed to improve the 






Subjects were identified from a prospective cohort study of 1591 self-identifying Hispanic/Latina women, 
aged 40-75, presenting for health care appointments at primary care centers located in the four Connecticut 
cities with the largest Hispanic/Latino populations (and 4 of the 5 largest cities in CT). Study subjects 
participated in an hour-long phone survey conducted in either English or Spanish, based upon the subject’s 
preference. Almost half of the cohort, 798 women, participated in a follow-up interview within 2-4 years 
of her entrance into the study. The average length of follow-up was 2.54 years.  One thousand seven hundred 
and thirty of the 2,137 women meeting the eligibility criteria (must have no prior history of breast cancer, 
breast biopsy, or cyst aspiration; aged 40-75; and availability for study) identified as potential participants 
were successfully contacted and 1,600 women were interviewed. Of these, 1591 were determined to be 
unique study subjects. This yielded a 75% participation rate among all eligible women and a 92% 
participation rate among women who could be contacted based on the information provided at the time of 
enrollment. Furthermore, 98% of study subjects provided written consent to abstract radiology records. 
Medical records were obtained from the screening facility that the study subject indicated as the place that 
they received a previous mammogram and/or would go to for a future mammogram. If the patient could 
not be identified from the radiology records in either facility, all facilities in this same locale were checked. 
Records for approximately 15% of study subjects who were identified as previous patients in a given facility 
but had no screening exams during the follow-up period were also searched in facilities serving the same 
geographic area. If such records were incomplete, surrounding facilities were checked to obtain additional 
data. Participants were compensated for their time (for both interviews) with gift cards to a large 
retail/grocery establishment. All study activities and analyses were approved by the Yale School of 
Medicine Human Investigation Committee. 
 
Inadequate Follow-Up 
Patient medical records were reviewed in order to determine the timing and type of each mammogram 
received by a subject. Screening mammograms were classified as abnormal or normal, based on the Breast 
Imaging Reporting and Data System (BI-RADS) criteria developed by the American College of Radiology 
(ACR) [7]. Table 1 defines the BI-RADS categories used to assess mammography results and the 
corresponding follow-up recommendations. Abnormal results were defined as BI-RADS category 0, 
incomplete; category 3, probably benign; category 4, suspicious abnormality; and category 5, highly 
suggestive of malignancy. Follow-up recommendations included immediate imaging follow-up (category 
0), short-term imaging follow-up within 6 months (category 3), and biopsy (categories 4 and 5). Normal 
results were defined as BI-RADS categories 1 and 2, mammograms that were negative or benign 
respectively, and a return to routine screening was recommended.  
For the 1570 (of 1591) women in the original study who provided written consent to review of 
mammography records, BI-RADS categories were obtained from those records. Of these, 247 women 
(15.7%) had abnormal (or inconclusive) results. For 58 of these women, the abnormal or inconclusive 
results were associated with one or more diagnostic tests, but no screening exam, and were thus excluded 
from the analysis. In total, 189 women were determined to have at least one abnormal or inconclusive 
screening mammogram during the follow-up period. A visual representation of this exclusion criteria is 
outlined in Figure 1. 
Outcome 
The outcome variable in this study was the receipt of adequate follow-up after an abnormal or inconclusive 
screening mammogram, dichotomized as yes or no. For the women requiring immediate follow-up (BI-
RADS categories 0,4,5), follow-up was considered adequate if the recommended diagnostic procedure was 
completed within three months of the screening mammogram. Subjects who received recommendations for 
short-term follow-up, (BI-RADS 3) were classified as receiving adequate follow-up if the recommended 
tests were completed within nine months of the index exam. Thus, regardless of the specific 
recommendation, a three-month grace period was applied before a study subject was classified as not 
receiving adequate follow-up. Any subject who received an abnormal mammogram and did not receive any 
form of diagnostic follow-up was classified as not receiving adequate follow-up; this process is outlined in 
Figure 1 and the distribution of BI-RADs results is presented in Table 1.  
Predictors 
A wide range of factors were evaluated in this analysis. These included socio-demographic, access to care, 
biomedical (e.g., family history, obesity, prior history of mammography screening), psychosocial, and 
acculturative factors as well as a number of variables that were specific to the experience of undergoing 
mammography screening. The coding of these variables is detailed in Tables 2 and 3 and indicated in the 
reported results. 
Data analysis  
All statistical analyses were performed with SAS 9.4 software (The SAS System for Windows. Cary, NC: 
SAS Institute Inc., Copyright 2002–2012). Bivariate associations between the predictor variables and the 
outcome variable, adequate follow-up, were assessed with χ2 tests (p < 0.05, two-sided). Independent 
predictors of adequacy of follow-up of an abnormal mammogram were identified using multivariate logistic 
regression methods; adjusted odds ratios (OR) with 95% confidence intervals (CI) are reported. All 
variables were modeled as categorical variables, based on results from preliminary analyses. Variables that 
were marginally significant in bivariate analyses (p < 0.25), or a priori were hypothesized to affect adequacy 
of follow-up and/or differ across adequacy groups based on results from previous studies, were tested in 
logistic regression models. Preliminary predictors were identified using the stepwise elimination method, 
which required a p-value ≤ 0.15 to enter the model initially and a p-value ≤ 0.10 to be retained. Variables 
that significantly improved the model fit using the maximum likelihood method remained in the final 
model[8]. 
Results 
There were 189 women who were recommended for either immediate (98.9%) or short-term follow-up 
(1.1%), as shown in Table 1. Over 31% of all women with abnormal or inconclusive results did not receive 
(or obtain) recommended follow-up testing (n=59). Women experiencing multiple instances of inadequate 
follow-up were rare, occurring for 12 subjects. Only 2 women were recommended for short-term follow-
up, both of whom did not receive follow-up within 9 months. 
Population Characteristics 
The characteristics of the study population are presented in Table 2.  Approximately half (48.7%) of the 
population was less than the age of 50, and the majority of the population (65.1%) was unmarried. This 
population was relatively low socioeconomic status, with 50.8% receiving less than HS education. Most 
(70.4%) of the population was not employed. Health insurance was common in the population (78.7%), 
with 86.6% of women indicating having a usual care provider. Seventy percent of women received at least 
one mammogram in the past year, and 6.6% of the population had a family history of breast cancer. Self-
rated health was low in the population, with 54.5% reporting a fair or poor perception of her health. Over 
half (50.3%) of the population had a body mass index (BMI) of over 30, classifying them as obese, and 
64.2% of these women had two or more comorbidities for breast cancer (which included diabetes, heart 
disease, high blood pressure, and high cholesterol). Twenty percent of women experienced a lot or a fair 
amount of pain during her mammography screening.  
The benefits of mammography screening were seen as very useful to 91.5% of the population, and 51.1% 
of women felt in control of her recovery if she were to be diagnosed with cancer. Almost a quarter (23.8%) 
of women did not perceive themselves as susceptible to breast cancer, and 25.8% of the population did not 
feel in control of their health outcomes overall1. Over half (52.4%) of the population was dependent on 
public transit or another driver in order to reach screening facilities; 22/3% of women needed to make 
special arrangements in order to make a screening appointment. These arrangements included coordinating 
transportation, arranging childcare, or locating someone to accompany the subject to the appointment. The 
majority of the population was not born in the United States (US); 70.7% of subjects were non-native 
women who have lived in the US for at least ten years. English proficiency was low in this population, with 
only 17.2% of women expressing confidence in their self-rated English speaking skills. The population was 
majority Puerto Rican born, with 55% indicating it as her country of origin. 
 
Potential Predictors 
From unadjusted comparisons presented in Table 3, factors that were significantly associated with 
inadequate follow-up in bivariate analyses were: BMI, self-rated health (SRH), and pain experienced during 
a mammogram. Bivariate analysis and a priori assumptions indicated that marital status, education, income, 
insurance status, acculturation, patient age, comorbidities, continuity of care, self-rated health, diabetes 
status, perceived control1, depression, total follow-up time, and receiving a mammogram in the past year 
should be assessed in multivariate analysis. Following stepwise elimination, patient age and a control over 
outcome1 index were added to the model. Table 4 presents the results of the multivariate model while 
controlling for the a priori predictors of marital status, education, insurance status, acculturation, 
comorbidities, receipt of mammogram in the past year, and continuity of care. 
  
Final Model 
In the final multivariate model, age, BMI, self-rated health, pain experienced during the mammogram, and 
perceived control over health outcomes were all independent predictors of inadequate follow up of an 
abnormal or inconclusive screening mammogram. Women under 50 were more likely to have inadequate 
follow-up compared to women over 50 (adjusted OR 3.12, 95% CI 1.31, 7.45), and obese women were 
significantly less likely than overweight/normal weight women to have inadequate follow-up (adjusted OR 
																																								 																				
1 The index was comprised of 3 separate indicators of patient attitudes towards their health and their abilities to 
address health issues as an individual 
0.35, 95% CI 0.16, 0.77). Women with a poor perception of self-rated health were more likely to experience 
inadequate follow-up than women with a positive perception of self-rated health (adjusted OR 2.42, 95% 
CI 1.09, 5.34), and women who experienced pain during the mammography screening were more likely to 
experience inadequate follow-up than women who did not (adjusted OR 2.75, 95% CI 1.11, 6.82). Women 
who believed they had low control over their health outcomes were less likely to have inadequate follow-
up (adjusted OR 0.25, 0.10, 0.68). 
 
Interaction Testing 
Additional testing of explanatory variables were added to the model in order to assess the strength of the 
identified predictors. Depression was tested as a potential mediator in the model, but it did not explain the 
increased risk associated with poor/self-rated health or mammography pain. Education was also tested as a 
mediator for self-rated health, mammography pain, and perception of control; all of these interactions were 
deemed insignificant. Interactions with the comorbidity variable – diabetes, high blood pressure, heart 
disease, and high cholesterol – were tested for subject BMI and self-rated health, and a modest potential 
interaction was observed between comorbidities and self-rated health (p=0.0579). Due to the relatively 
small sample size of the study, we lacked the statistical power to provide proper testing of interactions. 
However, stratified analysis between comorbidities and self-rated health indicated that the increased odds 
of inadequate follow-up only occurred amongst subjects with a poor self-rated health and multiple 
comorbidities (adjusted OR 2.50, 95% CI 0.90, 6.97). The multivariate model with stratified odds ratios for 
self-rated health by comorbidities are presented in Table 5. 
 
Discussion 
Considering the high risk of cancer mortality in Hispanic/Latino women, it is important to ensure that 
women who seek screening mammograms receive its benefits. Although only 12% of women required 
follow-up for a screening exam that was either abnormal or inconclusive, almost a third (59, 31.2%) of 
Hispanic/Latinas did not receive appropriate follow–up tests in a timely manner. This reduces the potential 
health benefits of screening mammograms.  
It is important to note that very few women (n=2) received a BI-RADS score of 3, which recommended 
short-term follow-up. This made it impossible to evaluate any differences in in follow-up based on short-
term or immediate follow-up recommendations. This is a significant departure from scores in our previous 
study focusing on Black women in 2005, in which 11.9% of abnormal BI-RADS scores recommended 
short-term follow-up[6]. Whether or not this is indicative of racial/ethnic differences in BI-RADS 
classifications or a change in physician practices over time, it is difficult to say. Regardless, it merits further 
investigation. 
The most robust finding of this study was the relationship between a woman’s BMI  and inadequate follow-
up (p=0.005). With studies associating post-menopausal women with an increased risk of developing breast 
cancer[9-11], it is interesting to note that these women are also more likely to receive adequate follow-up 
for an abnormal mammogram. Even after adjustment for other comorbidities and continuity of care, this 
result persisted. As there was no significant difference in patient knowledge of breast cancer guidelines, 
this could imply an effort at the physician/hospital-level to follow-up with these patients in particular. 
The perceived control index used for this study, which evaluated a subject’s self-perception of her control 
over her health outcomes, could bolster the idea of additional physician/hospital-level support in women 
who are seen as higher risk by the health system  (p=0.0067). The data suggest that lower perceived  control 
resulted in a higher likelihood of adequate follow-up. This lower perception of control could imply 
deferment to the recommendations of physicians and the health system. 
Initially, women who perceived themselves as less healthy were significantly less likely to receive adequate 
follow-up following an abnormal screening mammogram. However, this relationship disappeared 
following stratification by comorbidities.  Although this relationship was not statistically significant at the 
p<0.05 level, the stratification revealed distinct and opposing odds ratios for self-rated health. It is likely 
that in a larger population this relationship would be maintained or even strengthened. Regardless, the 
increased likelihood of inadequate follow-up was only present for individuals with a poor perception of 
their own health who possessed more than one comorbidity. The number of comorbidities was not as 
important as how a subject felt about her comorbidities, as women with a positive perception of their health 
with and multiple actually experienced a lower likelihood of inadequate follow-up.  As with our past study 
in which we examined predictors of inadequate follow up for abnormal screening exams in African 
American and White women[6], pain experienced during the mammogram itself was 2.24 times 
(statistically significant) more likely to result in inadequate follow-up for the subject. As both of these 
predictors are unique to each individual patient experience, it would be beneficial to obtain qualitative 
research in a similar population to identify the motivations behind not following up. 
Patient age was also a significant predictor of inadequate follow-up (p=0.0105), with younger subjects more 
likely to experience inadequate follow-up. Whether this indicates that subjects are less adept at navigating 
the system or if they are less prioritized by the healthcare system as ‘young and healthy’ – as most breast 
cancer screening recommendations begin at age 50[12] – is difficult to say.  
With our hour long interviews, we collected in-depth information on a full range of sociodemographic data 
that are not generally available in most studies. As such, the findings here are not related to 
sociodemographic variability within the study population, as is usually the case in disparities research; 
common findings of a lack of screening knowledge, language barriers, no insurance, and logistical obstacles 
were not present in our population [18-20]. This could be explained by the prospective nature of our study, 
or that the ethnic composition of Hispanic/Latinos in the Northeast is not generalizable. A limitation of the 
study was the small final sample size of abnormal mammograms within the population. This made it 
difficult to test for interactions between key terms in the model, though stratified analysis allowed insight 
into potential differences between groups. 
While inadequate follow-up of abnormal exams undermines the potential benefits of mammography 
screening for all women, the observed differences in this study may have implications for the persistent 
ethnic differences in breast cancer stage at diagnosis and survival. The key predictors of this model indicate 
both individual and system-level influences on the mammography screening effectiveness in 
Hispanic/Latino women, which opens the door for further research and intervention development based on 
these measures. In particular, qualitative research into understanding why subjects feel low levels of self-
rated health or what aspect of receiving a mammography is painful would be very helpful in crafting future 
studies and interventions in this population. As the first prospective cohort study in this population focusing 
on inadequate follow-up of screening mammograms, these findings offer robust and unique conclusions 
that should be taken into consideration for future research and interventions within this population.  
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Table 3 - Population Characteristics of Hispanic/Latinas living in Connecticut, US, aged 40-75 from 2009-2012 by adequacy of 




	 No	 Yes	 	 	
	 N=	59	(31.2%)	 N=	130	(68.8%)	 	 	
Characteristic	 Nb	 %	 Nb	 %	 	 	
Sociodemographic		 	 	 	 	 	 	
Age	(years)	 	 	 	 	 	 	
				40-49	 33	 34.0	 64	 66.0	 1.31	 0.71,	2.43	
				50+	 26	 28.3	 66	 71.7	 1.00	 	
Marital	status	 	 	 	 	 	 	
				Single	 40	 32.5	 83	 67.5	 1.19	 0.62,	2.29	
				Married/Partnered	 19	 28.8	 47	 71.2	 1.00	 	
Education	Level	 	 	 	 	 	 	
				<12	years	 30	 31.6	 65	 68.4	 1.00	 0.54,	1.86	
				≥12	years	 29	 31.5	 63	 68.5	 1.00	 	
Income	 	 	 	 	 	 	
				<$10,000	 22	 24.7	 67	 75.3	 0.55	 0.29,	1.05	
				≥$10,000	 34	 37.4	 57	 62.6	 1.00	 	
Employment	 	 	 	 	 	 	
				No	 41	 30.8	 92	 69.2	 0.94	 0.48,	1.84	
				Yes	 18	 32.1	 38	 67.9	 1.00	 	
	 	 	 	 	 	 	
Access	to	Care	 	 	 	 	 	 	
Insurance	Status	 	 	 	 	 	 	
				No	 16	 40.0	 24	 60.0	 1.63	 0.79,	3.36	
				Yes	 43	 29.0	 105	 71.0	 1.00	 	
Usual	Care	Provider	 	 	 	 	 	 	
				No	 11	 44.0	 14	 56.0	 1.87	 0.79,	4.40	
				Yes	 48	 29.6	 114	 70.4	 1.00	 	
Full	mammogram	
coverage	 	 	 	 	 	 	
No	 5	 29.4	 12	 70.6	 0.96	 0.32,	2.86	
Yes	 48	 30.4	 110	 69.6	 1.00	 	
	 	 	 	 	 	 	
Biomedical	Factors	 	 	 	 	 	 	
Mammogram	in	Last	
Year	 	 	 	 	 	 	
				No	 16	 28.6	 40	 71.4	 0.82	 0.41,	1.62	
				Yes	 43	 32.8	 88	 67.2	 1.00	 	
Family	History	of	breast	
cancerc	 	 	 	 	 	 	
Yes	 3	 27.3	 8	 72.7	 0.77	 0.20,	3.01	
No	 51	 32.9	 104	 67.1	 1.00	 	
Self-rated	Health	 	 	 	 	 	 	
				Fair/Poor	 39	 38.2	 63	 61.8	 2.01	 1.06,	3.82	
				Good/Very	
Good/Excellent	 20	 23.5	 65	 76.5	 1.00	 	
Body	Mass	Indexd	 	 	 	 	 	 	
Obese	 21	 22.8	 71	 77.2	 0.43	 0.23,	0.82	
Overweight/Normal	
Weight	 37	 40.7	 54	 59.3	 1.00	 	
Diabetes	 	 	 	 	 	 	
Yes	 17	 28.8	 42	 71.2	 0.83	 0.42,	1.63	
No	 42	 32.8	 86	 67.2	 1.00	 	
Comorbiditiese	 	 	 	 	 	 	
2+	 38	 31.7	 82	 68.3	 1.02	 0.53,	1.93	
0-1	 21	 31.3	 46	 68.7	 1.00	 	
Frequency	of	
Depressive	Feelings	 	 	 	 	 	 	
Often	 12	 26.1	 34	 73.9	 0.96	 0.32,	2.84	
Moderate	 40	 34.8	 75	 65.2	 1.45	 0.56,	3.74	
Rarely	 7	 26.9	 19	 73.1	 1.00	 	
Painful	mammography	 	 	 	 	 	 	
A	lot/fair	amount	 15	 41.7	 21	 58.3	 1.74	 0.82,	3.69	
No/a	little	 42	 29.2	 102	 70.8	 1.00	 	
Psychosocial	Factors	 	 	 	 	 	 	
Perceived	benefit	 	 	 	 	 	 	
Somewhat/a	little/not	
useful	 7	 43.8	 9	 56.2	 1.80	 0.64,	5.08	
Very	useful	 52	 30.2	 120	 69.8	 1.00	 	
Control	over	recovery	if	
diagnosed	with	cancer	 	 	 	 	 	 	
Some/a	little/none	 27	 29.7	 64	 70.3	 0.83	 0.45,	1.54	
A	lot	of	control	 32	 33.7	 63	 66.3	 1.00	 	
Perceived	susceptibility	
to	breast	cancer	 	 	 	 	 	 	
Not	at	all	 14	 31.1	 31	 68.9	 0.99	 0.48,	2.05	
A	little/somewhat/very	 45	 31.2	 99	 68.8	 1.00	 	
Control	Over	Outcomef	 	 	 	 	 	 	
Low	 10	 21.3	 37	 78.7	 0.51	 0.23,	1.11	
Moderate/High	 47	 34.8	 88	 65.2	 1.00	 	
Logistical	Barriers	 	 	 	 	 	 	
Transportationg	 	 	 	 	 	 	
Dependent	 34	 34.3	 65	 65.7	 1.36	 0.73,	2.53	
Independent	 25	 27.8	 65	 72.2	 1.00	 	
Special	Arrangements	 	 	 	 	 	 	
Yes	 16	 38.1	 26	 61.9	 1.47	 0.72,	3.02	
No	 43	 29.4	 103	 70.6	 1.00	 	
Work	Barriersh	 	 	 	 	 	 	
Yes	 10	 33.3	 20	 66.7	 1.11	 0.49,	2.55	
No	 49	 31.0	 109	 69.0	 1.00	 	
Acculturation	 	 	 	 	 	 	
Acculturation	 	 	 	 	 	 	
≥10	years	in	U.S.	 41	 30.8	 92	 69.2	 1.09	 0.46,	2.57	
<10	years	in	U.S.	 9	 37.5	 15	 62.5	 1.47	 0.47,	4.56	
				U.S.	Born	 9	 29.0	 22	 71.0	 1.00	 	
Self-rated	Spoken	
English	 	 	 	 	 	 	
				None/not	well	 46	 32.9	 94	 67.1	 1.29	 0.53,	3.12	
Very	well	 8	 27.6	 21	 72.4	 1.00	 	
Country	of	Origin	 	 	 	 	 	 	
				Foreign	born	 15	 27.8	 39	 72.2	 0.94	 0.35,	2.50	
Puerto	Rico	Born	 35	 33.7	 69	 66.3	 1.24	 0.52,	2.98	
				U.S.	Born	 9	 29.0	 22	 71.0	 1.00	 	












































Table 5 – Predictors associated with inadequate follow-up after abnormal screening mammography, Multivariate Logistic 





Age	(years)	 	 	 	
40-49	 	 3.19	 1.32,	7.70	
50+	 	 1.00	 	
Body	Mass	Index	 	 	 	






Self-rated	Health	 	 	 	
				Fair/Poor	 2+c		 2.50	 0.90,	6.97	
	 0-1	 0.95	 0.27,	3.29	
Good/Excellent	 2+	 0.54	 0.15,	1.89	
	 0-1	 1.00	 	
Painful	mammography	 	 	 	
A	lot/fair	amount	 	 2.55	 1.01,	6.42	





Low	Control	 	 0.27	 0.10,	0.73	
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